Metacognitive Intervention in Youth With Oncological Disease - the Mio Study

Summary

The aim of the Mio-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in children and adolescents with cancer. Through the use of the Mio-App, cognitive and physical development will be strengthened and metacognitive thinking and awareness will increase. The Mio-App for children and adolescence with cancer will include a combination of cognitive and physical training tasks and prospective as well as retrospective metacognitive questions. In a randomized controlled trial, the App will be analysed for its efficacy on metacognitive thinking and executive functions. In particular, the investigators are interested in factors that affect the efficacy of the training program such as compliance, age, sex or the presence of fatigue. This study will give insight into the role of metacognition in cognitive and physical performance and will foster the development of children and adolescents with cancer in the long-term.

Eligibility

Inclusion Criteria:

* Informed consent as documented by signature (see Informed Consent Form) of participants and / or parents / legal guardians
* Age 8-16 years
* A diagnosis of cancer either with or without CNS involvement. The participant will be included between 3 months before to 10 years after termination of treatment.
* Treatment of cancer including either radiation, chemotherapy and/ or surgical tumor removal
* German or French speaking

Exclusion Criteria:

* Any other instable neurological condition (e.g. epilepsy)
* A severe psychiatric disease (e.g., eating disorder) or severe learning disability
* Known or suspected non-compliance
* Drug or alcohol abuse
* Inability to follow the procedures of the study, e.g. due to language problems
* Enrolment of the investigator, his/her family members, employees and other dependent persons

Conditions1

Browse More Trials